Azithromycin for COVID-19 Treatment in Outpatients Nationwide

NCT04332107 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

263

Enrollment

OTHER

Sponsor class

Stopped Futility

Conditions

COVID-19
SARS-CoV-2

Interventions

DRUG: Azithromycin
DRUG: Placebos

Sponsor

Thomas M. Lietman

Collaborators

[object Object]
[object Object]
[object Object]